Welcome to CDC Stacks | Influenza antiviral medications : interim chemoprophylaxis and treatment guidelines - 25083 | Health Alert Network (HAN)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Influenza antiviral medications : interim chemoprophylaxis and treatment guidelines
  • Published Date:
    12/18/03
  • Source:
    HAN ; 171
  • Language:
    English
Filetype[PDF - 652.22 KB]


Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Series:
    HAN ; 171
  • Document Type:
  • Description:
    Thursday, December 18, 2003, 14:50 EST (02:50 PM EST)

    CDCHAN-00171-03-12-18-UPD-N

    (Posted to CDC Website: December 17, 2003)

    The following guidelines should be considered interim recommendations from CDC on the use of antiviral drugs for influenza during the 2003-04 influenza season. The interim guidelines were developed to provide clinicians and public health officials with guidance on the use of these drugs and will be updated over time as more information becomes available and more experience is gained.

    In the United States, oseltamivir and zanamivir (the neuraminidase inhibitors) and amantadine and rimantadine (the adamantanes) have been approved either for treatment or chemoprophylaxis of influenza, or for both. All of them are prescription medications. More detailed clinical information about these drugs, including dosages, approved indications and ages, and adverse effects can be found in Antiviral Agents for Influenza: Background Information for Clinicians and Prevention and Control of Influenza, Recommendations of the Advisory Committee on Immunization Practices (ACIP)

  • Supporting Files:
    No Additional Files